Nevro Corp 1N7
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if 1N7 is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $8.45
- Day Range
- $8.35–8.35
- 52-Week Range
- $7.95–152.00
- Bid/Ask
- $8.30 / $8.55
- Market Cap
- $306.68 Mil
- Volume/Avg
- 0 / —
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.77
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Nevro Corp is a medical device company. Its key product is the HFX spinal cord stimulation (SCS) platform, which includes the Senza SCS system, an evidence-based neuromodulation system for the treatment of chronic pain. Senza generates electrical impulses to relieve pain. The system is implanted by physicians and controlled by patients. It consists of leads, a trial stimulator, an implantable pulse generator, surgical tools, a clinician laptop programmer, a patient remote control, and a mobile charger. The company generates the majority of its revenue in the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 1,215
- Website
- https://www.nevro.com
Comparables
Valuation
Metric
|
1N7
|
SIBN
|
MMSI
|
---|---|---|---|
Price/Earnings (Normalized) | — | — | 26.05 |
Price/Book Value | 1.20 | 3.14 | 3.83 |
Price/Sales | 0.77 | 3.51 | 3.73 |
Price/Cash Flow | — | — | 20.95 |
Price/Earnings
1N7
SIBN
MMSI
Financial Strength
Metric
|
1N7
|
SIBN
|
MMSI
|
---|---|---|---|
Quick Ratio | 5.37 | 8.63 | 4.22 |
Current Ratio | 7.38 | 9.76 | 6.03 |
Interest Coverage | −6.96 | −13.62 | 6.17 |
Quick Ratio
1N7
SIBN
MMSI
Profitability
Metric
|
1N7
|
SIBN
|
MMSI
|
---|---|---|---|
Return on Assets (Normalized) | −5.06% | −7.83% | 9.17% |
Return on Equity (Normalized) | −10.23% | −10.72% | 15.14% |
Return on Invested Capital (Normalized) | −6.34% | −10.92% | 10.93% |
Return on Assets
1N7
SIBN
MMSI
Medical Devices Industry Comparables
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|---|
Abbott Laboratories
ABT
| Vxlzjwby | Ltgbln | $180.4 Bil | |||
Stryker Corp
SYK
| Cznlhvwfy | Nrhzh | $131.4 Bil | |||
Boston Scientific Corp
BSX
| Kkmfgxps | Fcjnbl | $112.9 Bil | |||
Medtronic PLC
MDT
| Zynfzbpt | Lcqjvhm | $106.3 Bil | |||
Edwards Lifesciences Corp
EW
| Qxnrkvyms | Ykgxs | $52.6 Bil | |||
DexCom Inc
DXCM
| Xwhhdxjv | Vkfv | $45.9 Bil | |||
Koninklijke Philips NV ADR
PHG
| Ssztldb | Rkyln | $24.3 Bil | |||
Zimmer Biomet Holdings Inc
ZBH
| Mdrykdjfc | Vtwp | $22.1 Bil | |||
Steris PLC
STE
| Wgzqmrnm | Flwkqf | $21.6 Bil | |||
Align Technology Inc
ALGN
| Grcpmlrq | Snxjt | $19.3 Bil |